[^99mTc]Tc-DTPA

Clinical Evaluation	Renal function
Type of Imaging	Scintigraphy
Grade of Recommendation	B (generally recommended)
Level of Evidence	well-designed NM recommendations
Effective Dose	4.9 µSv/MBq
Bibliographic Reference	Delgado Bolton, R. C., Aide, N., Colletti, P. M., Ferrero, A., Paez, D., Skanjeti, A., ... Giammarile, F. EANM guideline on the role of 2-[18F]... read more Delgado Bolton, R. C., Aide, N., Colletti, P. M., Ferrero, A., Paez, D., Skanjeti, A., ... Giammarile, F. EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA). Eur J Nucl Med Mol Imaging, 2021; https://doi.org/10.1007/s00259-021-05450-9. Salaün, P. Y., Abgral, R., Malard, O., Querellou-Lefranc, S., Quere, G., Wartski, M., ... Cachin, F. Good clinical practice recommendations for the use of PET/CT in oncology. Eur J Nucl Med Mol Imaging. 2020; https://doi.org/10.1007/s00259-019-04553-8. NCCN guidelines Version: 3.2021. Colombo, N., Sessa, C., du Bois, A., Ledermann, J., McCluggage, W. G., McNeish, I., ... Vergote, I. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Ann Oncol. 2019; https://doi.org/10.1093/annonc/mdz062. read less
Guide to Nuclear Medicine	Read the corresponding chapter

Clinical Evaluation
Renal function
Type of Imaging
Scintigraphy
Grade of Recommendation
B (generally recommended)
Level of Evidence
well-designed NM recommendations
Effective Dose
4.9 µSv/MBq
Bibliographic Reference
Delgado Bolton, R. C., Aide, N., Colletti, P. M., Ferrero, A., Paez, D., Skanjeti, A., ... Giammarile, F. EANM guideline on the role of 2-[18F]... read more Delgado Bolton, R. C., Aide, N., Colletti, P. M., Ferrero, A., Paez, D., Skanjeti, A., ... Giammarile, F. EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA). Eur J Nucl Med Mol Imaging, 2021; https://doi.org/10.1007/s00259-021-05450-9. Salaün, P. Y., Abgral, R., Malard, O., Querellou-Lefranc, S., Quere, G., Wartski, M., ... Cachin, F. Good clinical practice recommendations for the use of PET/CT in oncology. Eur J Nucl Med Mol Imaging. 2020; https://doi.org/10.1007/s00259-019-04553-8. NCCN guidelines Version: 3.2021. Colombo, N., Sessa, C., du Bois, A., Ledermann, J., McCluggage, W. G., McNeish, I., ... Vergote, I. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Ann Oncol. 2019; https://doi.org/10.1093/annonc/mdz062. read less
Guide to Nuclear Medicine
Read the corresponding chapter

[99mTc]Tc-DTPA

[^99mTc]Tc-DTPA